US Patent Issued to EPICENTRX on July 15 for "Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone" (California Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,607, issued on July 15, was assigned to EPICENTRX INC. (La Jolla, Calif.).

"Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone" was invented by Bryan T. Oronsky (Los Altos Hills, Calif.), Jan Scicinski (Saratoga, Calif.) and Scott Caroen (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone (ABDNAZ), including formulations containing, autologous whole blood and ABDNAZ that can be rapidly administered to a patient by intravenous infusion without any significant pain...